Welcome to LookChem.com Sign In|Join Free

CAS

  • or

658082-39-4

Methyl 1-oxo-1,2-dihydroisoquinoline-7-carboxylate is a chemical compound derived from isoquinoline, a heterocyclic organic compound. It is known for its potential pharmaceutical applications and is used as a building block in organic synthesis. Its molecular structure and functional groups make it suitable for further modification and development of new pharmaceutical products.

658082-39-4 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 658082-39-4 Structure

  • Basic information

    1. Product Name: Methyl 1-oxo-1,2-dihydroisoquinoline-7-carboxylate
    2. Synonyms: Methyl 1-oxo-1,2-dihydroisoquinoline-7-carboxylate;methyl 1-hydroxyisoquinoline-7-carboxylate
    3. CAS NO:658082-39-4
    4. Molecular Formula: C11H9NO3
    5. Molecular Weight: 203.19406
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 658082-39-4.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: Sealed in dry,Room Temperature
    8. Solubility: N/A
    9. CAS DataBase Reference: Methyl 1-oxo-1,2-dihydroisoquinoline-7-carboxylate(CAS DataBase Reference)
    10. NIST Chemistry Reference: Methyl 1-oxo-1,2-dihydroisoquinoline-7-carboxylate(658082-39-4)
    11. EPA Substance Registry System: Methyl 1-oxo-1,2-dihydroisoquinoline-7-carboxylate(658082-39-4)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 658082-39-4(Hazardous Substances Data)

658082-39-4 Usage

Uses

Used in Pharmaceutical Industry:
Methyl 1-oxo-1,2-dihydroisoquinoline-7-carboxylate is used as a building block in organic synthesis for the development of new pharmaceutical products. Its molecular structure and functional groups make it a promising candidate for the creation of novel drugs for various medical conditions.
Used in Anti-Cancer Applications:
Methyl 1-oxo-1,2-dihydroisoquinoline-7-carboxylate is studied for its potential as an anti-cancer agent. Its unique molecular structure and functional groups allow for further modification and development of new pharmaceutical products that can target and treat cancer cells.
Used in Neurodegenerative Disease Therapy:
Methyl 1-oxo-1,2-dihydroisoquinoline-7-carboxylate is also being studied for its potential as a therapeutic agent for neurodegenerative diseases. Its molecular properties and functional groups make it a promising candidate for the development of new treatments that can help manage and alleviate the symptoms of these conditions.
Research on Methyl 1-oxo-1,2-dihydroisoquinoline-7-carboxylate continues to explore its potential as a valuable tool in the development of novel drugs for various medical conditions, making it an important compound in the field of pharmaceuticals.

Check Digit Verification of cas no

The CAS Registry Mumber 658082-39-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,5,8,0,8 and 2 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 658082-39:
(8*6)+(7*5)+(6*8)+(5*0)+(4*8)+(3*2)+(2*3)+(1*9)=184
184 % 10 = 4
So 658082-39-4 is a valid CAS Registry Number.

658082-39-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl 1-oxo-2H-isoquinoline-7-carboxylate

1.2 Other means of identification

Product number -
Other names Methyl 1-oxo-1,2-dihydroisoquinoline-7-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:658082-39-4 SDS

658082-39-4Relevant articles and documents

INHIBITORS OF ENL/AF9 YEATS

-

Paragraph 00304-00305, (2021/06/26)

Methods and compositions for treating leukemia are disclosed. Acylated 6-aminoindoles, acylated 6-aminopyrrolopyridines and acylated 3-aminopyrrolo[3,2-c]pyridazines of the following formula inhibit ENL/AF9 YEATS and are therefore useful for treating leukemia.

BICYCLIC COMPOUNDS

-

Paragraph 00258, (2020/06/01)

Provided herein are compounds and pharmaceutical compositions comprising said compounds that are useful for treating cancers. Specific cancers include those that are mediated by YAP/TAZ or those that are modulated by the interaction between YAP/TAZ and TEAD.

SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF

-

Page/Page column 75, (2012/04/23)

This invention provides compounds of formula (I): wherein R1a, R1b, Ra, R2a, R2b, R1, and X have values as described in the specification, useful as inhibitors of HDAC6. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of proliferative, inflammatory, infectious, neurological or cardiovascular diseases or disorders.

ISOQUINOLINE DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS

-

Page/Page column 112, (2008/06/13)

This invention provides compounds defined by Formula I or a pharmaceutically acceptable salt thereof, wherein R1, Q, Y, R2, R3, R4, R5, and n are as defined in the specification ás MMP-13 enzyme inhib

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 658082-39-4